Clincosm LogoSign in Get a demo

homologous recombination deficiency

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Homologous Recombination Deficiency
  • (no location specified)
Oct 18, 2023

Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

Recruiting
  • Castration-resistant Prostate Cancer
  • Homologous Recombination Deficiency
  • Testosterone Enanthate 100 MG/ML Injectable Solution
  • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Homologous Recombination Deficiency, Triple Negative Breast Cancer Trial (Niraparib)

Not yet recruiting
  • Homologous Recombination Deficiency
  • Triple Negative Breast Cancer
  • (no location specified)
Jul 15, 2022

HRD and Resistance to PAPPi in EOC Patients

Recruiting
  • Epithelial Ovarian Cancer
  • +6 more
  • Testing of homologous recombination deficiency
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

Completed
  • Epithelial Ovarian Cancer
  • +6 more
  • Evaluation of homologous recombination deficiency score
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency Trial in Korea, Republic of

Recruiting
  • Solid Tumors
  • +2 more
  • Goyang, Gyeongggi-do, Korea, Republic of
  • +17 more
Jan 20, 2022

Solid Tumor, Adult, Homologous Recombination Deficiency Trial in Washington, Hackensack, Charlotte (Niraparib, Carboplatin)

Recruiting
  • Solid Tumor, Adult
  • Homologous Recombination Deficiency
  • Washington, District of Columbia
  • +2 more
Aug 31, 2021

Mesothelioma, Homologous Recombination Deficiency Trial in Chicago (Olaparib)

Recruiting
  • Mesothelioma
  • Homologous Recombination Deficiency
  • Chicago, Illinois
    University of Chicago Medical Center
May 12, 2021

Ovarian Tumor Epithelial, Homologous Recombination Deficiency, BRCA1 Mutation Trial in Groningen, Leiden, Rotterdam (Functional

Recruiting
  • Ovarian Neoplasm Epithelial
  • +3 more
  • Functional RAD51 assay
  • Olaparib Oral Product
  • Groningen, Netherlands
  • +2 more
Mar 30, 2021

A Training Set for the HRD Model in EOC

Recruiting
  • Epithelial Ovarian Cancer
  • +5 more
  • Homologous recombination deficiency model
  • Beijing, Beijing, China
    Lei Li
Dec 2, 2020

Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

Unknown status
  • Ovarian Neoplasms
  • +23 more
  • Nanjing, Jiangsu, China
    JiangSu Cancer Hospital
Nov 8, 2020

Homologous Recombination Deficiency Status in Epithelial Ovarian

Unknown status
  • Epithelial Ovarian Cancer
  • +5 more
  • Genomic testing
  • Beijing, Beijing, China
    Lei Li
Dec 6, 2019

ATM Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial (Epacadostat, Pembrolizumab)

Withdrawn
  • ATM Gene Mutation
  • +9 more
  • (no location specified)
May 28, 2019